130 related articles for article (PubMed ID: 3082642)
1. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
Splinter TA; Romijn JC
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
Herr HW; Kleinert EL; Relyea NM; Whitmore WF
Cancer; 1984 Mar; 53(6):1294-8. PubMed ID: 6420041
[TBL] [Abstract][Full Text] [Related]
3. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of two polyamine antimetabolites combined with mitomycin C on human stomach cancer cells xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Okui K
Int J Cancer; 1985 Jun; 35(6):821-5. PubMed ID: 3924844
[TBL] [Abstract][Full Text] [Related]
5. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
Dunzendorfer U; Knöner M
Onkologie; 1985 Aug; 8(4):196-200. PubMed ID: 2419811
[TBL] [Abstract][Full Text] [Related]
6. Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].
Warrell RP; Coonley CJ; Burchenal JH
Cancer Chemother Pharmacol; 1983; 11(2):134-6. PubMed ID: 6414731
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.
Levin VA; Chamberlain MC; Prados MD; Choucair AK; Berger MS; Silver P; Seager M; Gutin PH; Davis RL; Wilson CB
Cancer Treat Rep; 1987 May; 71(5):459-64. PubMed ID: 3105881
[TBL] [Abstract][Full Text] [Related]
8. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice.
Kramer DL; Paul B; Porter CW
Cancer Res; 1985 Jun; 45(6):2512-5. PubMed ID: 3921245
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
[TBL] [Abstract][Full Text] [Related]
10. [Anticancer treatment with a combination of antimetabolites of polyamine and pyrimidine].
Fujimoto S; Shrestha RD; Igarashi K; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Ohta M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2024-9. PubMed ID: 2932057
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.
Herr HW; Warrel RP; Burchenal JH
Urology; 1986 Dec; 28(6):508-11. PubMed ID: 3097903
[TBL] [Abstract][Full Text] [Related]
12. Combined use of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in normal and leukemia-bearing mice.
Seppänen P; Alhonen-Hongisto L; Jänne J
Cancer Lett; 1983 Feb; 18(1):1-10. PubMed ID: 6402294
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Endoh F; Ohta M; Togawa Y; Okui K
Jpn J Surg; 1986 Mar; 16(2):133-9. PubMed ID: 2941608
[TBL] [Abstract][Full Text] [Related]
14. Regulation of epidermal proliferation in mouse epidermis by combination of difluoromethyl ornithine (DFMO) and methylglyoxal bis(guanylhydrazone) (MGBG).
McCullough JL; Peckham P; Klein J; Weinstein GD; Jenkins JJ
J Invest Dermatol; 1985 Dec; 85(6):518-21. PubMed ID: 3934288
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG).
Gastaut JA; Tell G; Schechter PJ; Maraninchi D; Mascret B; Carcassonne Y
Cancer Chemother Pharmacol; 1987; 20(4):344-8. PubMed ID: 3121203
[TBL] [Abstract][Full Text] [Related]
16. Polyamines increase in human peripheral blood and bone marrow mononuclear cells following administration of methylglyoxal bis(guanylhydrazone).
Maddox AM; Keating MJ; Freireich EJ; Haddox MK
Chemotherapy; 1988; 34(5):419-29. PubMed ID: 3141118
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antileukemic effect of two polyamine synthesis inhibitors. Host survival and cell-cycle kinetic analysis.
Ask A; Persson L; Oredsson SM; Heby O
Int J Cancer; 1986 Mar; 37(3):465-70. PubMed ID: 3081454
[TBL] [Abstract][Full Text] [Related]
18. Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: phase I evaluation of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) treatment of human hematological malignancies.
Maddox AM; Freireich EJ; Keating MJ; Haddox MK
Cancer Res; 1988 Mar; 48(5):1367-73. PubMed ID: 3124958
[TBL] [Abstract][Full Text] [Related]
19. Combined use of alpha-difluoromethylornithine and an inhibitor of S-adenosylmethionine decarboxylase in mice bearing P388 leukemia or Lewis lung carcinoma.
Nakaike S; Kashiwagi K; Terao K; Iio K; Igarashi K
Jpn J Cancer Res; 1988 Apr; 79(4):501-8. PubMed ID: 3133338
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy with a combination of hyperthermochemotherapy and thermosensitization with polyamine antimetabolites in nude mice.
Fujimoto S; Shrestha RD; Ohta M; Igarashi K; Endoh F; Kokubun M; Koike S; Togawa Y; Okui K
Jpn J Surg; 1987 Mar; 17(2):110-7. PubMed ID: 3114528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
